CHARLES RIVER LABORATORIES (CRL) Stock News
NYSE:CRL - New York Stock Exchange, Inc. - US1598641074 - Common Stock - Currency: USD
CRL Latest News, Press Releases and Analysis
Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
Top S&P500 movers in Thursday's session
Top movers analysis one hour before the close of the markets of S&P500 on 2025-01-16: top gainers and losers in today's session.
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.
Which S&P500 stocks are moving on Thursday?
Which S&P500 stocks are gapping on Thursday?
Looking for the S&P500 stocks that are experiencing notable gaps on Thursday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform
Tuesday's session: top gainers and losers in the S&P500 index
Top S&P500 movers in Tuesday's session
Which S&P500 stocks are moving on Tuesday?
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
Gapping S&P500 stocks in Tuesday's session
Tuesday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
Charles River Introduces Global Biotech Incubator Program
Charles River Laboratories to Present at Evercore ISI Investor Conference
Charles River Laboratories to Present at UBS and Jefferies Conferences
Charles River Laboratories Announces Third-Quarter 2024 Results
Charles River Launches New Retrogenix® Non-Human Protein Library
Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
Charles River Provides Translational Expertise at Neuroscience 2024
Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease
Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research
Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
/PRNewswire/ -- Charles River Laboratories International, Inc. (NYSE: CRL) and Insightec, a global healthcare company dedicated to using focused ultrasound to...
Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
